Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01137825Recruiting
Older patient cancer registry for a health check
This study is a registry that collects information from older adults who may be dealing with cancer. It includes a short health and function check to help doctors understand needs and guide care, even for people who turn out not to have cancer.
Boone, North CarolinaAges 65 years+ - NCT00900575Recruiting
Test optical scans to detect cervical cancer during care
This study tests whether special light-based scans (optical spectroscopy) can help detect cervical cancer. It may be done around colposcopy, and participants may also be monitored with follow-up Pap smears after treatment.
Durham, North CarolinaAges 18 years+ - NCT00923442Enrolling by invitation
Study of blood cancers’ biology using stored or new tissue
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
Bethesda, MarylandAges 1–120 - NCT00027326Enrolling by invitation
Blood and Urine Study During Radiation Therapy
This study collects blood and urine samples from patients receiving radiation therapy to understand how the body responds to treatment. It may help researchers improve radiation therapy in the future.
Bethesda, MarylandAges 18–120 - NCT01109394Recruiting
Help study tumors with sample testing and a research biology library
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
Washington D.C., District of ColumbiaAges 4 weeks+ - NCT01109420Recruiting
Family study of non-medullary thyroid cancer and genetics
This study looks at families affected by non-medullary thyroid cancer to understand patterns and possible genetic risk. You may be able to join even if you personally do not have the cancer, as long as you have the right family history and can complete a questionnaire.
Bethesda, MarylandAges 7–90 - NCT00006518Recruiting
Tissue samples from people with viral infections or cancer
This study collects tissue and blood samples from people who have or have been exposed to certain viruses (HIV, KSHV, HPV, EBV, or HTLV-1) or who have developed cancer or precancerous skin lesions. The samples help researchers understand how these viruses may lead to cancer.
Bethesda, MarylandAges 18–120 - NCT01247597Recruiting
Study of DICER1-related tumor history in families
This study follows people affected by DICER1-related tumors (and sometimes family members) to better understand how these conditions develop over time. It may help families by improving knowledge and guiding genetic counseling and future care.
Bethesda, MarylandAges 1 month–99 years - NCT00923065Enrolling by invitation
NCI care and data study for patients and donors
This study helps collect information and provide certain clinical care and interventions for people who come to the National Cancer Institute (NCI) Clinical Center (CCR). It may be a fit if you need NCI-level evaluation or support because your condition is complex, or if you’re involved as a cellular therapy donor or certain family members needing genetic testing.
Bethesda, MarylandAges 4 weeks–120 years - NCT01087333Recruiting
Share blood samples to help study blood cancers and treatments
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
Bethesda, MarylandAges 18 years+ - NCT00026650Recruiting
Understanding Long-Term Effects After Radiation Therapy
This study follows patients who have received radiation therapy to learn about long-term health effects and how the disease progresses over time. By tracking your health over the years, researchers hope to better understand and help future patients manage side effects.
Bethesda, MarylandAges 18–120 - NCT04941716RecruitingPhase 2
Combination therapy for relapsed or refractory chronic lymphocytic leukemia
This trial tests two targeted drugs, acalabrutinib and venetoclax, taken together for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or not responded to previous treatment. The goal is to see if this combination helps control the disease and improves outcomes.
Seattle, WashingtonAges 18 years+ - NCT07008638RecruitingPhase 1/Phase 2
Treatment for newly diagnosed AML with a TP53 mutation
This study tests a combination of two drugs, bortezomib and CPX-351, for people with a specific type of acute myeloid leukemia (AML) that has a change in the TP53 gene. The purpose is to see if this combination is safe and effective.
Minneapolis, MinnesotaAges 18 years+ - NCT07042919RecruitingPhase 1/Phase 2
Zanzalintinib for advanced liver cancer after prior treatment
This trial tests a new pill called zanzalintinib for people with advanced liver cancer that has grown after earlier treatments. It aims to see if the drug can shrink tumors and help patients live longer.
Chicago, IllinoisAges 18 years+ - NCT06816459RecruitingEarly Phase 1
Sensory tests of cigarette flavors in daily adult smokers
This study tests how well you can smell different flavors in cigarettes. It will help researchers understand how flavor affects smoking, which may lead to better ways to help people cut back or quit.
Buffalo, New YorkAges 21 years+ - NCT07892027RecruitingPhase 2
Preventing brain side effects during car t-cell therapy
This study tests whether giving a drug called natalizumab before CAR T-cell therapy can lower the risk of a serious side effect that affects the brain and nervous system (called ICANS). It is for people with diffuse large B-cell lymphoma or mantle cell lymphoma that has come back or not responded to treatment.
Ann Arbor, MichiganAges 18 years+ - NCT04107285Recruiting
Cognitive and brain changes in people getting CAR-T therapy
This study looks at how CAR-T therapy, a type of cancer treatment that uses your own immune cells, may affect your thinking and brain. By tracking these changes, doctors hope to better support patients during and after treatment.
New York, New YorkAges 18 years+ - NCT02984761Recruiting
Surgery or radiation for early-stage lung cancer
This study compares two standard treatments for early-stage non-small cell lung cancer: surgery to remove the tumor versus a precise type of radiation (stereotactic radiotherapy). The goal is to see which treatment is better for overall health and quality of life.
Long Beach, CaliforniaAges 18 years+ - NCT06644430Recruiting
Tumor ablation for lung spots in advanced liver cancer
This trial tests whether destroying a small number of lung tumors with ablation can help people with advanced liver cancer who are already on systemic therapy. Ablation uses heat or cold to target tumors directly, which may slow the cancer's growth and improve outcomes.
Beijing, Beijing MunicipalityAges 18–80 - NCT06422806RecruitingPhase 3
Immunotherapy plus chemo for aggressive sarcoma
This trial compares a combination of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) versus chemotherapy alone for people with aggressive, poorly differentiated sarcomas that have spread or cannot be removed. The goal is to see if adding immunotherapy helps shrink tumors or slow their growth better than chemotherapy alone.
Phoenix, ArizonaAges 18 years+ - NCT07654257RecruitingPhase 2
Single radiation treatment after breast surgery
This trial tests a one-time radiation treatment given directly to the area where your breast cancer was removed. It aims to reduce the need for multiple radiation sessions and may be an option for certain patients with early-stage breast cancer.
Richmond, VirginiaAges 40–85 - NCT05675410RecruitingPhase 3
Testing two-drug treatment versus standard for Hodgkin lymphoma
This Phase 3 study compares today’s standard treatment for classic Hodgkin lymphoma with a new combination using brentuximab vedotin and nivolumab. The goal is to see which approach works better and is safe for newly diagnosed patients with early-stage disease.
Birmingham, AlabamaAges 5–60 - NCT06279013Recruiting
Phone check-ins to manage symptoms during oral cancer treatment
This study tests two ways of using telephone check-ins to help people manage side effects and emotional distress while taking oral anti-cancer pills at home. If you are starting or recently started an oral anti-cancer drug, you may be able to join.
Phoenix, ArizonaAges 18 years+ - NCT07246330RecruitingPhase 3
Continued immunotherapy after chemoradiation for advanced esophageal cancer
This trial tests whether continuing a type of immunotherapy (toripalimab) after standard chemoradiation helps keep advanced esophageal cancer from growing, compared to just watching and waiting. If you've already completed initial treatment without the cancer getting worse, this study might help you stay stable longer.
Tianjin, Tianjin MunicipalityAges 18–75
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.